FDC Ltd Stock Falls to 52-Week Low of Rs.357.45 Amidst Weak Financial Performance

Feb 06 2026 11:12 AM IST
share
Share Via
Shares of FDC Ltd, a player in the Pharmaceuticals & Biotechnology sector, declined sharply to hit a new 52-week low of Rs.357.45 on 6 February 2026, marking a significant milestone in the stock’s ongoing downward trajectory.
FDC Ltd Stock Falls to 52-Week Low of Rs.357.45 Amidst Weak Financial Performance

Recent Price Movement and Market Context

On the day in question, FDC Ltd’s stock price touched an intraday low of Rs.357.45, representing a 4.83% drop from the previous close. The stock underperformed its sector by 1.49% and has recorded losses over the last two consecutive trading sessions, cumulatively falling by 5.35% during this period. This decline places the stock well below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling sustained bearish momentum.

In contrast, the broader market benchmark, the Sensex, opened flat but traded slightly lower by 0.21% at 83,142.34 points, remaining 3.63% shy of its 52-week high of 86,159.02. While the Sensex is trading below its 50-day moving average, the 50DMA itself remains above the 200DMA, indicating a mixed but relatively stable market environment compared to the sharper decline seen in FDC Ltd’s shares.

Long-Term Performance and Valuation Metrics

Over the past year, FDC Ltd’s stock has delivered a negative return of 24.18%, significantly underperforming the Sensex, which posted a positive 6.52% return over the same period. The stock’s 52-week high was Rs.528.30, highlighting the extent of the recent decline. This underperformance extends beyond the last year, with the stock lagging behind the BSE500 index across one-year, three-year, and three-month time frames.

From a valuation standpoint, FDC Ltd maintains a Price to Book Value ratio of 2.5, which is considered fair relative to its peers’ historical averages. The company’s Return on Equity (ROE) stands at 9.3%, reflecting moderate profitability. Additionally, the company’s debt profile remains conservative, with an average Debt to Equity ratio of zero, indicating no reliance on borrowed funds for capital structure.

This week's revealed pick, a Large Cap from Public Banks with TARGET PRICE, is already showing movement! Get the complete analysis before it's too late.

  • - Target price included
  • - Early movement detected
  • - Complete analysis ready

Get Complete Analysis Now →

Financial Results and Profitability Trends

FDC Ltd’s recent quarterly financials reveal a decline in profitability. The Profit Before Tax excluding other income (PBT LESS OI) for the quarter stood at Rs.36.37 crores, down 31.2% compared to the average of the previous four quarters. Similarly, the Profit After Tax (PAT) for the quarter was Rs.44.47 crores, reflecting a 21.1% decrease relative to the prior four-quarter average. These figures underscore a weakening earnings trend in the near term.

The company’s Return on Capital Employed (ROCE) for the half-year period is reported at 12.51%, marking the lowest level observed recently. This metric indicates the efficiency with which the company is utilising its capital base to generate profits and suggests a contraction in operational returns.

Institutional Investor Activity

Institutional investors have reduced their holdings in FDC Ltd by 0.66% over the previous quarter, now collectively owning 8.59% of the company’s shares. Given that institutional investors typically possess greater analytical resources and insight into company fundamentals, this reduction in stake may reflect a cautious stance on the stock’s prospects based on current performance metrics.

Comparative Sector and Market Position

Within the Pharmaceuticals & Biotechnology sector, FDC Ltd’s performance has been subdued relative to peers. The stock’s Mojo Score stands at 26.0, accompanied by a Mojo Grade of Strong Sell as of 3 November 2025, a downgrade from its previous Hold rating. This grading reflects concerns over the company’s growth trajectory and financial health compared to sector benchmarks.

Operating profit growth has been negative over the last five years, with an annualised decline of 5.46%. This long-term contraction in operating profitability contrasts with the sector’s generally positive growth trends and contributes to the cautious market sentiment surrounding the stock.

FDC Ltd or something better? Our SwitchER feature analyzes this small-cap Pharmaceuticals & Biotechnology stock and recommends superior alternatives based on fundamentals, momentum, and value!

  • - SwitchER analysis complete
  • - Superior alternatives found
  • - Multi-parameter evaluation

See Smarter Alternatives →

Profitability and Return Analysis

Over the past year, FDC Ltd’s profits have declined by 28.8%, a figure that aligns with the negative stock returns over the same period. The company’s ROE of 9.3% indicates moderate returns on shareholder equity, but this has not been sufficient to support positive price momentum in the stock.

The stock’s market capitalisation grade is rated at 3, reflecting its relative size and liquidity characteristics within the market. Despite a low debt burden, the company’s earnings and profitability metrics have not met investor expectations, contributing to the downward pressure on the share price.

Summary of Key Metrics

To summarise, FDC Ltd’s stock has reached a 52-week low of Rs.357.45 after a sustained period of underperformance. Key financial indicators such as declining quarterly profits, subdued operating profit growth, and reduced institutional participation have weighed on the stock. The company’s valuation remains fair relative to peers, but this has not translated into positive price action amid broader sector and market dynamics.

While the Sensex and sector indices have shown resilience, FDC Ltd’s share price continues to reflect the challenges faced by the company in maintaining growth and profitability momentum.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Are FDC Ltd latest results good or bad?
Feb 05 2026 07:18 PM IST
share
Share Via
FDC Ltd is Rated Strong Sell
Feb 01 2026 10:10 AM IST
share
Share Via
FDC Ltd is Rated Strong Sell
Jan 21 2026 10:10 AM IST
share
Share Via
FDC Ltd is Rated Strong Sell
Jan 10 2026 10:10 AM IST
share
Share Via
Why is FDC Ltd falling/rising?
Jan 10 2026 01:04 AM IST
share
Share Via